Most people who experience a first gout flare will have a second one within a year. About 75% of gout patients have another attack in that window, though some go years between episodes. How often flares recur depends heavily on uric acid levels, diet, and whether you’re on long-term treatment.
The Typical Pattern After a First Attack
A first gout flare usually resolves within one to two weeks, even without treatment. What follows is a quiet stretch, sometimes called the intercritical period, where you feel completely normal. No pain, no swelling. This can trick people into thinking gout was a one-time event.
It rarely is. Three out of four people have a second flare within 12 months. For people whose uric acid levels return to normal after that first episode, the one-year recurrence rate drops to about 12%. But for those whose levels stay elevated, the rate climbs to roughly 45%. This gap highlights why uric acid is the single biggest predictor of how often flares come back.
What Makes Flares More Frequent
Uric acid levels have a dose-response relationship with flare frequency, meaning the higher your levels, the more often you’ll have attacks. Data from a large clinical trial showed that patients with uric acid levels of 10 mg/dL or higher had more than four times the flare rate compared to those in the 4 to 6 mg/dL range. Even levels between 8 and 10 mg/dL nearly tripled the rate. Keeping uric acid below 6 mg/dL is the standard treatment target for this reason.
Diet plays a measurable role in triggering individual flares. A study tracking gout patients found that high-purine meals increased the risk of an attack within the next two days by nearly fivefold, comparing the highest intake levels to the lowest. This effect held regardless of sex, alcohol use, or whether the person was taking medication. Red meat, organ meats, shellfish, and beer are among the most concentrated purine sources.
Flares also follow a circadian pattern. Attacks are 2.4 times more likely to strike between midnight and 8 a.m. than during the daytime. Several factors converge while you sleep: body temperature drops to its lowest point around 2 to 6 a.m., which makes uric acid crystals more likely to form in joints. You’re also mildly dehydrated from hours without fluids, and your body’s natural cortisol (a built-in anti-inflammatory) hits its lowest level around midnight to 4 a.m.
How Flares Change Over Time Without Treatment
Left unmanaged, gout tends to escalate. Early on, you might have one or two flares a year with long pain-free gaps between them. Over years, the pattern shifts. Flares come more often, last longer, and can start affecting multiple joints instead of just one. The classic first target is the big toe, but untreated gout eventually spreads to ankles, knees, wrists, and fingers.
After roughly 10 years of recurrent, undertreated gout, many patients develop tophi, which are visible lumps of uric acid crystals that form under the skin near joints. At this stage, the disease is no longer episodic. It becomes chronic gouty arthritis with persistent pain and potential joint damage. This progression isn’t inevitable, but it is the natural course when uric acid stays elevated for years.
How Treatment Reduces Flare Frequency
Urate-lowering therapy is the main strategy for spacing out and eventually stopping flares. These medications work by reducing how much uric acid your body produces or by helping your kidneys clear more of it. The goal is to dissolve the crystal deposits that have built up in your joints over years.
There’s an important catch: when you first start treatment, flares often temporarily increase. As crystals begin to dissolve, they can trigger new inflammation. In one study, before starting treatment, patients averaged two to four flares in six months. During the first six months of therapy, about 49% of patients were still having more than one flare per six-month period. By the second six months, that dropped to 43%, and 57% of patients had either zero flares or just one.
To bridge this rocky start, doctors typically prescribe a low-dose anti-inflammatory to take daily alongside the urate-lowering medication. In clinical trials, this approach cut flare rates dramatically. Only 33% of patients on prophylaxis experienced a flare over six months, compared to 77% on placebo. The optimal duration for this preventive medication appears to be seven to nine months. Patients who stopped at three to six months had a 54% chance of a flare within a year, while those who continued for seven months or longer had roughly a 25% chance.
Over the long run, if uric acid stays at target levels, flares can stop entirely. By the second year of sustained treatment, many patients report no attacks at all. The key word is sustained. Gout is a chronic condition, and stopping medication typically brings flares back as uric acid rises again.
What You Can Realistically Expect
If you’ve had one gout flare and aren’t on medication, expect another one within the next year, most likely. If you’ve had multiple flares, expect them to become more frequent over time. The trajectory without treatment is clear: more attacks, longer attacks, more joints involved.
With consistent treatment and uric acid levels kept in range, the picture reverses. Flares become less frequent within months, and many people become flare-free within one to two years. The people who struggle most are those who start and stop treatment, since each interruption can trigger a new round of flares as uric acid rebounds. Staying hydrated, limiting high-purine foods, and moderating alcohol all help reduce flare risk on top of medication, but diet alone rarely keeps uric acid low enough to prevent recurrence in people who’ve already had gout.